Division of Nephrology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, PR China.
Shanghai Institute of Kidney Disease and Dialysis, Shanghai, PR China.
Ren Fail. 2021 Dec;43(1):198-205. doi: 10.1080/0886022X.2021.1871921.
Intradialytic hypotension (IDH) is a common complication in maintaining hemodialysis (MHD) patients. Immune activation might be part of the mechanisms. However, the association between pro-inflammatory cytokines and blood pressure (BP) has not been deeply explored. So we aim to evaluate the potential role of pro-inflammatory cytokines in IDH.
MHD patients starting hemodialysis before January 2016 were enrolled in our retrospective study. Patients' characteristics, laboratory results, and intradialytic BP were collected. IDH was defined as nadir systolic BP ≤ 90 mmHg during hemodialysis. The definition of IDH group was that those who suffered from more than one hypotensive event during one month after the enrollment (10% of dialysis treatments). Spearman correlation analysis and logistic regression were employed to explore the relationship between pro-inflammatory cytokines and IDH.
Among 390 patients, 72 were identified with IDH (18.5%). High levels of serum tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were observed in the IDH group ( < 0.001). Both TNF-α and IL-1β positively correlated with predialysis BP ( < 0.01). Receiver operating characteristic curve (ROC) analysis was used to evaluate the diagnostic accuracy of serum IL-1β and TNF-α for IDH. The area under the curve of IL-1β was 0.772 (95% CI: 0.708-0.836, < 0.01), and that of TNF-α was 0.701 (95% CI: 0.620-0.781, < 0.01). After adjusting for patients' characteristics, biochemical parameters, comorbid conditions, predialysis BP, and medications, elevated TNF-α and IL-1β were still risk factors for IDH.
Pro-inflammatory cytokines (TNF-α and IL-1β) could be potential predictors for IDH.
透析中低血压(IDH)是维持性血液透析(MHD)患者的常见并发症。免疫激活可能是其中的部分机制。然而,促炎细胞因子与血压(BP)之间的关系尚未被深入探讨。因此,我们旨在评估促炎细胞因子在 IDH 中的潜在作用。
我们进行了一项回顾性研究,纳入了 2016 年 1 月前开始血液透析的 MHD 患者。收集了患者的特征、实验室结果和透析中血压。IDH 定义为透析过程中收缩压最低值≤90mmHg。IDH 组的定义是在入组后一个月内(10%的透析治疗)发生一次以上低血压事件的患者。采用 Spearman 相关分析和逻辑回归分析来探讨促炎细胞因子与 IDH 之间的关系。
在 390 例患者中,有 72 例患者发生 IDH(18.5%)。IDH 组患者的血清肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)水平较高(均 < 0.001)。TNF-α 和 IL-1β 与透析前 BP 呈正相关(均 < 0.01)。受试者工作特征曲线(ROC)分析用于评估血清 IL-1β 和 TNF-α 对 IDH 的诊断准确性。IL-1β 的曲线下面积为 0.772(95%CI:0.708-0.836, < 0.01),TNF-α 的曲线下面积为 0.701(95%CI:0.620-0.781, < 0.01)。在校正了患者特征、生化参数、合并症、透析前 BP 和药物治疗后,升高的 TNF-α 和 IL-1β 仍然是 IDH 的危险因素。
促炎细胞因子(TNF-α 和 IL-1β)可能是 IDH 的潜在预测因子。